B, P., F, Z., WJ, R., R, C., A, C., A, P., . . . Investigators, R. A. E. S. (1999). The effect of spironolactone on morbidity and mortality in patients with severe heart failure. New England Journal of Medicine, 341(10), 709.
Chicago Style (17th ed.) CitationB, Pitt, Zannad F, Remme WJ, Cody R, Castaignge A, Perez A, Palensky J, Wittes J, and Randomized Aldactone Evaluation Study Investigators. "The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure." New England Journal of Medicine 341, no. 10 (1999): 709.
MLA (9th ed.) CitationB, Pitt, et al. "The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure." New England Journal of Medicine, vol. 341, no. 10, 1999, p. 709.